MRCP, FRCPath, PhD
I am a Senior Lecturer in Haematology at Queen Mary University of London and a Consultant Haemato-Oncologist at St Bartholomew’s Hospitals and The Barts Health NHS Trust, London UK. My expertise is in the treatment of blood cancers and in stem cell transplantation for these diseases.
I have a specialist interest in chronic lymphocytic leukaemia. I am a recognised expert in the field of infections in immunocompromised patients with cancer and a world authority on life-threatening invasive fungal infections. I qualified at the University of Bristol and subsequently trained at the Royal Marsden Cancer Hospital, being awarded my PhD “1st class with honours” (in Immunology) at the University of Paris. I am a fluent French speaker.
I am former Director of The Stem Cell Laboratory and Head of Diagnostic Immunophenotyping. I have designed, funded, and implemented studies on myelodysplastic syndromes, invasive aspergillosis, and chronic lymphocytic leukaemia. I was a founding Trustee of the UK MDS group and formerly a member of the UK MDS and CLL trials committee. I am a trustee for CLLSA (the patient-led support organisation for patients in the UK with CLL), as well as a NICE reviewer and the Haemato-Oncology representative on the UK IVIg initiative.
My current activities are in the field of invasive fungal disease, chronic lymphocytic leukaemia, systems for “remote care” for patients and empowering patients by giving them their data through secure online databases. I am a member of the fungal subgroup of government committee on antimicrobial resistance, ESPAUR.
I am the former Director of The Stem Cell Laboratory and Head of Diagnostic Immunophenotyping. I have designed, funded, and implemented studies on myelodysplastic syndromes, invasive aspergillosis, and chronic lymphocytic leukaemia.